GABA Labs Ltd

Company Overview GABA Labs Ltd is a pioneering, science-driven company dedicated to revolutionizing adult social drinking by developing functional ingredients that replicate the positive effects of alcohol without its associated harms. Their mission is to provide better options for adult social drinkers, enhancing mood and supporting social connection through innovative products. Key Offerings SENTIA : An award-winning range of functional drinks that utilize natural ingredients to enhance mood and promote social interaction. SENTIA is currently available in the UK, US, and EU markets. Alcarelle : A patentable biomimetic ingredient designed to promote conviviality and relaxation. Alcarelle is intended to be licensed to beverage companies, enabling them to create a new generation of alcohol alternative beverages. The ingredient is set to enter the regulatory process in the US (FDA GRAS) in 2025. Scientific Foundation GABA Labs' scientific work is led by Chief Scientific Officer, Professor David Nutt, a renowned neuropsychopharmacologist with over 30 years of research into the effects of substances on stress, anxiety, and relaxation. The company's approach combines neuropsychopharmacology, bioprospecting, and the use of AI to develop functional alternatives to alcohol. Consumer Engagement Industry and consumer response to GABA Labs' mission has been encouraging. The company actively engages with various stakeholders, including consumers, bar owners, mixologists, ingredients companies, drinks brands, and public health organizations, to understand their needs and gather feedback on their products. Regulatory and Research Initiatives GABA Labs is committed to ensuring the safety and efficacy of its products through rigorous regulatory processes. Alcarelle is undergoing the FDA GRAS (Generally Recognized As Safe) process in the US, with plans to enter in 2025. The company also collaborates with research institutions internationally, seeking proposals for in vitro pharmacological and physiological profiling of Alcarelle and SENTIA to further validate their products' effects. Leadership Team The leadership team at GABA Labs includes: David Orren : Managing Director with 20 years of international experience in enabling disruptive technologies to secure market engagement. Professor David Nutt : Chief Scientific Officer, a psychiatrist and neuropsychopharmacologist with extensive experience in the study of the brain, drugs, and conditions such as addiction, anxiety, and sleep. Contact Information For more information or inquiries, please visit the GABA Labs Contact Page .